Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 140
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
Has Results
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Cancer, Adult Solid Tumor, Lymphoma Trial in United States

Recruiting
  • Cancer
  • +3 more
    • Birmingham, Alabama
    • +39 more
    Sep 28, 2021

    Multiple Myeloma Trial in United States (hLL1-DOX (the doxorubicin conjugate of milatuzumab))

    Terminated
    • Multiple Myeloma
    • hLL1-DOX (the doxorubicin conjugate of milatuzumab)
    • Orlando, Florida
    • +4 more
    Aug 12, 2021

    Multiple Myeloma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

    Terminated
    Has Results
    • Multiple Myeloma
    • Antineoplaston therapy (Atengenal + Astugenal)
    • Houston, Texas
      Burzynski Clinic
    May 17, 2021

    Multiple Myeloma Trial in United States (Oprozomib, Pomalidomide, Dexamethasone)

    Terminated
    Has Results
    • Multiple Myeloma
    • Encinitas, California
    • +16 more
    Mar 31, 2021

    Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

    Completed
    • Multiple Myeloma
    • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
    • +4 more
    • Birmingham, Alabama
    • +30 more
    Mar 31, 2021

    Multiple Myeloma Trial in United States (Oprozomib, Lenalidomide, Dexamethasone)

    Terminated
    Has Results
    • Multiple Myeloma
    • Huntsville, Alabama
    • +13 more
    Mar 2, 2021

    Multiple Myeloma Trial in United States (Lenalidomide 15mg, Lenalidomide 25mg)

    Completed
    Has Results
    • Multiple Myeloma
    • Lenalidomide 15mg
    • Lenalidomide 25mg
    • Little Rock, Arkansas
    • +6 more
    Jan 5, 2021

    Connect® MM- The Multiple Myeloma Disease Registry

    Active, not recruiting
    • Multiple Myeloma
      • Huntsville, Alabama
      • +252 more
      Jan 21, 2021

      Lymphoma, Leukemia, Multiple Myeloma Trial in Australia, Germany, United States (LBH589)

      Completed
      Has Results
      • Lymphoma
      • +2 more
      • Augusta, Georgia
      • +6 more
      Dec 16, 2020

      Multiple Myeloma Trial in Worldwide (LGH447, midazolam)

      Completed
      • Multiple Myeloma
      • Chicago, Illinois
      • +7 more
      Dec 16, 2020

      Multiple Myeloma Trial in Philadelphia, Houston (CD3/CD28)

      Completed
      Has Results
      • Multiple Myeloma
      • CD3/CD28
      • Philadelphia, Pennsylvania
      • +1 more
      Dec 2, 2020

      Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

      Active, not recruiting
      • Leukemia
      • +9 more
      • Fludarabine monophosphate
      • +5 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 2, 2020

      Multiple Myeloma Trial in United States (Bortezomib)

      Completed
      Has Results
      • Multiple Myeloma
      • Little Rock, Arkansas
      • +10 more
      Aug 23, 2020

      Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

      Completed
      • Hematological Neoplasms
      • +19 more
      • Scottsdale, Arizona
      • +9 more
      May 11, 2020

      Multiple Myeloma Trial in United States (Lenalidomide)

      Completed
      Has Results
      • Multiple Myeloma
      • Tucson, Arizona
      • +41 more
      Apr 27, 2020

      Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

      Completed
      Has Results
      • Cancer
      • +5 more
      • Tucson, Arizona
      • +308 more
      Mar 19, 2020

      Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Phoenix, Arizona
      • +209 more
      Mar 8, 2020

      Myelodysplastic Disorders, Leukemia, Multiple Myeloma Trial in Houston (FLUDARABINE, CAMPATH 1H, FK50)

      Completed
      • Myelodysplastic Disorders
      • +4 more
      • Houston, Texas
      • +1 more
      Jan 15, 2020

      Etiology of Multiple Myeloma: A Case-Control Study

      Unknown status
      • Multiple Myeloma
      • Questionnaire
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 29, 2019

      Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

      Completed
      • Cancer
      • +7 more
      • Scottsdale, Arizona
      • +9 more
      Nov 27, 2019

      Multiple Myeloma Trial in United States (Bortezomib, Romidepsin)

      Terminated
      Has Results
      • Multiple Myeloma
      • Loma Linda, California
      • +11 more
      Nov 14, 2019